Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial
The TRILUMINATE trial demonstrated that transcatheter edge-to-edge repair (TEER) using the TriClip device for symptomatic severe tricuspid regurgitation (TR) was safe and significantly reduced heart failure hospitalizations compared to medical therapy alone over a two-year follow-up, according to a study presented by Dr. Saibal Kar, Los Robles Regional Medical Center, USA, in the Late-Breaking Clinical Trials session at ACC.25.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Recommendations
